1-5 of 5
Hana Frankova, MD
Close
Sort by
Journal Articles

Comparative Effectiveness of Daratumumab Monotherapy Versus a Real-World Historical Control from the Czech Republic in Heavily Pretreated and Highly Refractory Multiple Myeloma Patients

Roman Hájek, Tomas Jelinek, MD, Vladimir Maisnar, MD PhD, Ludek Pour, Ivan Spicka, MD PhD, Jiri Minarik, MD PhD, Evzen Gregora, MD, Petr Kessler, MD, Michal Sykora, MD, Hana Frankova, MD, Dagmar Adamova, MD, Marek Wróbel, Peter Mikula, MD, Jiri Jarkovsky, MSc, PhD, Xenia Gatopoulou, Sarka Vesela, Joris Diels, PhD, Hervé Besson, PhD, Lucie Brozova, MSc, Tetsuro Ito
Journal: Blood
Blood (2016) 128 (22): 3332.
https://doi.org/10.1182/blood.V128.22.3332.3332
Published: 2016
Journal Articles

Multiple Myeloma R-ISS Prognostic Stratification System in Real Life Population

Jakub Radocha, MD PhD, Vladimír Maisnar, MD PhD, Ludek Pour, MD PhD, Zdenek Adam, MD PhD, Ivan Spicka, MD PhD, Jan Straub, MD, Vlastimil Scudla, prof, MD PhD, Jiri Minarik, MD PhD, Evzen Gregora, MD, Petr Pavlicek, MD, Hana Frankova, MD, Lenka Zahradova, MD PhD, Alexandra Jungova, MD, Michal Sykora, MD, Petr Kessler, MD, Dagmar Adamova, MD, Marek Wrobel, MD, Lenka Sedlarikova, MSc, Sabina Sevcikova, RNDr, PhD, Daniel Horinek, Ing, Jana Pelcova, MSc, Jiri Jarkovsky, MSc, PhD, Roman Hájek
Journal: Blood
Blood (2016) 128 (22): 3333.
https://doi.org/10.1182/blood.V128.22.3333.3333
Published: 2016
Journal Articles

Registry of Monoclonal Gammopathies (RMG) in the Czech Republic

Jakub Radocha, MD PhD, Ludek Pour, MD PhD, Ivan Spicka, MD PhD, Vlastimil Scudla, MD PhD, Evzen Gregora, MD, Hana Frankova, MD, Roman Hajek, MD, Miroslava Schutzova, MD, Michal Sykora, MD, Petr Kessler, MD, Dagmar Adamova, MD, Marek Wrobel, MD, Lenka Sedlarikova, MSc, Sabina Sevcikova, RNDr, PhD, Daniel Horinek, MSc, Jana Pelcova, Bc, Lucie Brozova, Mgr, Jiri Jarkovsky, MSc, PhD, Vladimir Maisnar, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4514.
https://doi.org/10.1182/blood.V126.23.4514.4514
Published: 2015
Journal Articles

Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.

Roman Hajek Prof, MD, Ivan Spicka, MD, PhD, Vlastimil Scudla, MD, Evzen Gregora, MD, Vladimir Maisnar, MD, PhD, Miroslava Schutzova, MD, Elena Tothova Prof, MD, Martin Mistrik, MD, PhD, Marta Krejci, MD, PhD, Jan Straub, MD, Jiri Minarik, MD, Jakub Radocha, MD, Vladimir Koza, MD, PhD, Petr Pavlicek, MD, Libuse Novosadova, MD, Hana Frankova, MD, Yvetta Stavarova, MD, Petr Kessler, MD, Lenka Walterova, MD, Jaromir Gumulec, MD, Adam Svobodnik, PhD, Dana Kralova, Zdenek Adam, MD
Journal: Blood
Blood (2007) 110 (11): 531.
https://doi.org/10.1182/blood.V110.11.531.531
Published: 2007
Journal Articles

Low Molecular Weight Heparin in Sufficient Dose of ≥70 IU/kg as an Effective and Safe Thromboprophylaxis in Patients with Newly Diagnosed Multiple Myeloma during Conventional VAD Induction Therapy.

Ludek Pour, MD, Petr Kessler, MD, Evzen Gregora, MD, Marketa Zemanova, MD, Miroslav Penka, MD, Jaromir Gumulec, MD, Zdenek Adam, MD, Bacovsky Jaroslav, MD, PhD, Hana Frankova, MD, Kamila Havlikova, MD, Frantisek Lehanka, MD, Vladimir Maisnar, PhD, Ivana Meluzinova, MD, Yvetta Stavarova, MD, Jan Straub, MD, Adam Svobodnik, PhD, Vlastimil Scudla, MD, Elena Sumna, MD, Lenka Walterova, MD, Roman Hajek, MD
Journal: Blood
Blood (2007) 110 (11): 2732.
https://doi.org/10.1182/blood.V110.11.2732.2732
Published: 2007